510(k) K161100
K161100 is an FDA 510(k) premarket notification submitted by Contamac, Ltd. for the device "Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses". The FDA issued a decision of Substantially Equivalent on August 10, 2016. The device falls under product code HQD (Lens, Contact (Other Material) - Daily), a Class II device regulated under 21 CFR 886.5916. Contamac, Ltd. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 10, 2016
- Date Received
- April 19, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Lens, Contact (Other Material) - Daily
- Device Class
- Class II
- Regulation Number
- 886.5916
- Review Panel
- OP
- Submission Type